Table 2 Changes in average morning SBP of patients with anxiety and without anxiety during the COVID-19 period
The COVID-19 period | Adjusted mean (95% CI) of SBP, mmHg* | Adjusted mean difference (95% CI) of SBP (∆SBP), mmHg‡ | The between-group difference in ∆SBP | P§ | |||
---|---|---|---|---|---|---|---|
Without anxiety (GAD-7 ≤ 4) (n = 3462) | With anxiety (GAD-7 ≥ 5) (n = 262) | P* | Without anxiety (GAD-7 ≤ 4) (n = 3462) | With anxiety (GAD-7 ≥ 5) (n = 262) | |||
Pre-epidemic period | 130.9 (130.6, 131.2) | 132.0 (130.9, 133.2) | 0.07 | ||||
Incubation period | 131.3 (130.9, 131.6)† | 132.7 (131.5, 133.9) | 0.03 | 0.4 (0.2, 0.6) | 0.6 (−0.2, 1.3) | 0.2 (−0.6, 1.0) | 0.58 |
Developing period | 131.5 (131.1, 131.8)† | 132.8 (131.7, 134.0)† | 0.05 | 0.5 (0.3, 0.8) | 0.7 (−0.1, 1.6) | 0.2 (−0.7, 1.1) | 0.65 |
Outbreak period | 130.7 (130.4, 131.0)† | 132.9 (131.7, 134.1)† | <0.001 | −0.3 (−0.5, −0.02) | 0.9 (−0.02, 1.8) | 1.2 (0.3, 2.2) | 0.01 |
Plateau period | 130.0 (129.6, 130.3)† | 132.7 (131.6, 133.9) | <0.001 | −0.9 (−1.2, −0.7) | 0.8 (−0.2, 1.7) | 1.7 (0.7, 2.7) | <0.001 |